ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation
Clinical trial NCT01067820 · COMPLETED
Trial details
- NCT number
- NCT01067820
- Sponsor
- Resverlogix Corp
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2013-05-01
- Enrollment
- 324
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.